Introduction
============

Oral cancer is a serious public health problem worldwide [@B1]. It is believed that oral cancer is a complex disease caused by both genetic and environmental factors, as well as their interactions. Epidemiology studies have indicated that environmental factors including tobacco smoking, alcohol consumption and betel-quid chewing contribute to the development of oral cancer [@B2]. In addition, genetic factors also play important roles in the pathogenesis of oral cancer.

Most tobacco carcinogens are metabolized by enzymatic complex mechanisms involving both activation (phase I) and detoxification (phase II) reactions [@B3]. The detoxification efficiency of GST enzymes is determined by the presence, amount, and nature of the isoenzymes coded by *GSTT1*, *GSTM1*, and *GSTP1* genes [@B4]. The deleted variants of the *GSTM1* and *GSTT1* loci result in loss of functional activity [@B5]. The polymorphism at codon 105 of *GSTP1* gene has been reported to cause differences in catalytic activity. In other words, electrophilic compounds are reported to be detoxified less efficiently in individuals with variant genotypes of *GSTP1* (Ile/Val and Val/Val) when compared with those with wild-type genotype [@B6]. Recently, a meta-analysis has indicated that the *GSTM1* null genotype may be associated with a higher risk of oral cancer in Asians but not in Caucasians; the *GSTT1* null genotype may not be associated with oral cancer [@B7]. However, no meta-analysis has examined the association between *GSTP1*Ile105Val polymorphism and risk of oral cancer, although many individual studies have been published with inconsistent results [@B8]-[@B18]. Thus, in this study, we performed a meta-analysis to clarify the association between *GSTP1*Ile105Val polymorphism and risk of oral cancer.

Materials and methods
=====================

Literature and search strategy
------------------------------

Literature databases including PubMed and Embase were searched. The search strategy to identify all possible studies involved the use of the following key words: (GSTP1 or glutathione S-transferase P1) and (variant or variation or polymorphism) and oral cancer. The publication language was restricted to English. The reference lists of retrieved articles were manually searched. If more than one article were published using the same data, only the study with largest sample size was included. The literature search was updated on December 12, 2012.

Inclusion criteria and data extraction
--------------------------------------

The studies included in the meta-analysis must meet all the following inclusion criteria: (1) evaluating the association between *GSTP1*Ile105Val polymorphism and oral cancer; (2) using case-control or cohort design; (3) providing sufficient data for calculation of odds ratio (OR) with 95% confidence interval (CI). The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) country; (4) ethnicity; (5) sample size of cases and controls; (6) source of controls; (7) covariates\' adjusted OR with 95%CI under a dominant model; and (8) whether or not the genotypes in Hardy-Weinberg equilibrium (HWE) in controls. The two authors independently assessed the articles for compliance with the inclusion/exclusion criteria, resolved disagreements and reached a consistent decision.

Statistical analysis
--------------------

The association between *GSTP1*Ile105Val polymorphism and oral cancer was estimated by calculating pooled adjusted OR with 95% CI under a dominant genetic model. The significance of pooled OR was determined by *Z* test (*p*\<0.05 was considered statistically significant). Q test was performed to evaluate to the between-study heterogeneity. A random- (DerSimonian-Laird method [@B19]) or fixed- (Mantel-Haenszel method [@B20]) effects model was used to calculate pooled OR in the presence (*p*\<=0.10) or absence (*p*\>0.10) of heterogeneity, respectively. Subgroup analysis by ethnicity, whether adjustment for smoking status (no vs. yes), and number of cases (n\<150 vs n≥150) was performed. Publication bias was assessed by Begg\'s test [@B21] and Egger\'s test [@B22] (*p*\<0.05 was considered statistically significant). Data analysis was performed using STATA version 11 (StataCorp LP, College Station, Texas, USA).

Results
=======

Characteristics of the studies
------------------------------

A flow chart of inclusion/exclusion of the individual studies was presented as Figure [1](#F1){ref-type="fig"}. The literature search identified a total of 55 potentially relevant papers. Of these, 37 papers were excluded because of obvious irrelevance by reading the titles and abstracts. In addition, two papers were excluded because they examined the association between*GSTP1*Ile105Val polymorphism and head-and-neck cancer [@B23], [@B24]; one paper was excluded because it investigated the association between *GSTP1* Ile105Val polymorphism and the combined cancer including lip, oral cavity/oropharynx cancer [@B25]; one paper was excluded because it examined the association between *GSTP1*Ile105Val polymorphism and arsenic-induced cancer [@B26]. Then, 14 papers met the primary inclusion criteria [@B8]-[@B18], [@B27]-[@B29]. In addition, two papers were excluded because they did not provide sufficient data for calculation of OR with 95%CI [@B27],[@B28]; one paper was excluded because it examined the association between *GSTP1*mitochondrial polymorphisms and oral cancer [@B29]. It should be noted that since the paper by Kotoh, et al. [@B9] provided the data stratified for smoking status and the paper by Park, et al. [@B10] provided the data stratified for ethnicity, they were considered as separate studies in the following data analysis. At last, 13 studies (1803 oral cancer cases and 2998 controls) were included in the final meta-analysis. The characteristics of the included studies are listed in Table [1](#T1){ref-type="table"}.

Meta-analysis results
---------------------

The results indicated that there was no significant association between *GSTP1*Ile105Val polymorphism and oral cancer in the overall population (OR=1.13, 95%CI=0.92-1.38, *I*^2^=48.0%, *p* for heterogeneity=0.027, Fig [2](#F2){ref-type="fig"} and Table [2](#T2){ref-type="table"}). Further subgroup analysis by ethnicity suggested that *GSTP1*Ile105Val polymorphism was significantly associated with oral cancer only in East Asians (OR=1.64, 95%CI=1.16-2.31, *I*^2^=0.0%, *p* for heterogeneity=0.525), but not in Caucasians (OR=1.16, 95%CI=0.73-1.82, *I*^2^=7.5%, *p* for heterogeneity=0.299), Africans (OR=1.10, 95%CI=0.37-3.28), South Asians (OR=1.20, 95%CI=0.69-2.08, *I*^2^=74.3%, *p* for heterogeneity=0.021) and mixed populations (OR=0.91, 95%CI=0.70-1.20, *I*^2^=39.7%, *p* for heterogeneity=0.174) (Fig [3](#F3){ref-type="fig"} and Table [2](#T2){ref-type="table"}). In the stratified analysis by whether adjustment for smoking status, the effect size was significant in studies not adjusting for smoking status (OR=1.61, 95%CI=1.15-2.24,*I*^2^=0.0%,*p* for heterogeneity=0.494), but was not significant in studies controlling for smoking status (OR=1.02, 95%CI=0.83-1.25, *I*^2^=39.7%, *p* for heterogeneity=0.093) (Table [2](#T2){ref-type="table"}). However, in studies with number of cases more than 150 or less than 150, the effect size was both not significant (Table [2](#T2){ref-type="table"}).

Potential publication bias
--------------------------

No publication bias was detected for the association between *GSTP1*Ile105Val polymorphism and oral cancer (Begg\'s test: *p*=0.127; Egger\'s test: *p*=0.114).

Discussion
==========

To our knowledge, this is the first meta-analysis investigating the association between *GSTP1*Ile105Val polymorphism and oral cancer risk. The present meta-analysis including 1803 oral cancer cases and 2998 controls did not support the significant association between *GSTP1*Ile105Val polymorphism and oral cancer risk in the overall population. However, *GSTP1*Ile105Val polymorphism was significantly associated with oral cancer in East Asians.

Recently, many meta-analyses have been performed to investigate the association between *GSTP1*Ile105Val polymorphism and many types of cancer risk (e.g., prostate cancer [@B30], gastric cancer [@B31], esophageal cancer [@B32], head and neck cancer [@B33], lung cancer [@B34], breast cancer [@B35], ovarian cancer [@B36] and thyroid cancer [@B37]). The results indicated that *GSTP1*polymorphism was not significantly associated with prostate cancer [@B30], esophageal cancer [@B32], head and neck cancer [@B33], lung cancer [@B34], ovarian cancer [@B36] and thyroid cancer [@B37]; this polymorphism might contribute to the development of gastric cancer [@B31] or breast cancer [@B35] in East Asians, but not in other ethnic populations. However, besides our study, these meta-analyses did not consider the effect of gene-gene and gene-environment interactions in the development of cancer. One polymorphism with modest effect may be not associated with cancer susceptibility, but the synthesis of many genes or gene gene-environment interactions might increase cancer risk.

In this meta-analysis, we used covariate\'s adjusted OR with 95% CI to calculate the pooled estimate, thus, more precise effect was obtained. However, some potential limitations in our study should be considered. First, gene-gene and gene-environment interactions were not addressed in our meta-analysis. However, we further performed subgroup analysis based on whether adjustment for smoking status. The result indicated that smoking strengthened the effect of the Ile105Val polymorphism on oral cancer. Second, most individual studies only provided adjusted OR with 95% CI under a dominant model. Thus, we are unable to estimate the effect of Ile105Val polymorphism under other genetic models, such as co-dominant model, recessive model and additive model. Third, there was significant between-study heterogeneity for Ile105Val polymorphism. We performed subgroup analysis based on ethnicity and the heterogeneity only existed in South Asians, suggesting this subgroup population is the source of between-study heterogeneity.

In summary, the present meta-analysis has limited evidence to support the association of *GSTP1*Ile105Val polymorphism with risk of oral cancer. However, *GSTP1*Ile105Val polymorphism might be associated with risk of oral cancer in East Asians. Further large-scale studies with the consideration for gene-gene/gene-environment interactions should be conducted to investigate the association.
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###### 

Characteristics of the studies included in the meta-analysis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                           Country    Ethnicity     No. of cases   No. of controls   Dominant model   Source of controls   Adjustment ^\*^    In HWE             
  ------------------------------- ---------- ------------- -------------- ----------------- ---------------- -------------------- ------------------ ------------------ -----
  Jourenkova-\                    France     Caucasian     67             172               1.50             0.80-3.00            Hospital-based     1, 2, 3, 4, 5      Yes
  Mironova, 1999 [@B8]                                                                                                                                                  

  Kotoh,1999 (Non-smoker) [@B9]   Japan      East Asian    30             122               1.48             0.67-3.31            Hospital-based     1, 2               Yes

  Kotoh,1999 (Smoker) [@B9]       Japan      East Asian    53             122               2.78             1.06-7.51            Hospital-based     1, 2               Yes

  Park,1999 (Caucasian) [@B10]    USA        Caucasian     104            175               0.94             0.53-1.70            Hospital-based     3, 5               Yes

  Park,1999 (African) [@B10]      USA        African       53             85                1.10             0.36-3.20            Hospital-based     3, 5               Yes

  Sikdar, 2004 [@B11]             India      South Asian   256            259               2.00             1.00-4.00            Hospital-based     1,2,3              Yes

  Leichsenring, 2006 [@B12]       Brazil     Mixed         72             60                1.40             0.70-2.79            Hospital-based     None               Yes

  Peters, 2006 [@B13]             USA        Mixed         352            753               1.06             0.81-1.38            Population-based   1, 2, 3, 5, 6      Yes

  Hatagima, 2008 [@B14]           Brazil     Mixed         231            212               0.78             0.56-1.17            Hospital-based     1, 2, 3, 5, 6      Yes

  Chen, 2010 [@B15]               China      East Asian    164            274               1.53             1.01-2.31            Hospital-based     2                  Yes

  Yadav, 2010 [@B16]              India      South Asian   136            270               1.35             0.86-2.13            Hospital-based     3, 5, 7            Yes

  Karen-Ng, 2011 [@B17]           Malaysia   Mixed         115            116               0.65             0.39-1.09            Hospital-based     1, 2, 4, 5, 6,,7   Yes

  Ruwali, 2011 [@B18]             India      South Asian   170            500               0.75             0.54-1.12            Hospital-based     2, 3, 4,5          Yes
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\*^ 1, sex; 2; age; 3, tobacco consumption; 4, cigarette consumption; 5, alcohol consumption; 6, race; 7, betel quid chewing OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.

###### 

Meta-analysis of the association between *GSTP1* Ile105Val variant and oral cancer under a dominant model.

                               No. of studies   OR     95 %CI      *P* z   Statistical model   *I*^2^ (%)   *P* ~H~
  ---------------------------- ---------------- ------ ----------- ------- ------------------- ------------ ---------
  **All**                      13               1.13   0.92-1.38   0.243   Random              48.0         0.027
  **Ethnicity**                                                                                             
  Caucasian                    2                1.15   0.74-1.79   0.523   Fixed               7.5          0.299
  East Asian                   3                1.64   1.16-2.31   0.005   Fixed               0.0          0.525
  South Asian                  3                1.20   0.69-2.08   0.524   Random              74.3         0.021
  Mixed                        4                0.93   0.77-1.13   0.703   Fixed               39.7         0.174
  African                      1                1.10   0.37-3.28   0.475   \-                  \-           \-
  **Adjustment for smoking**                                                                                
  No                           3                1.61   1.15-2.24   0.005   Fixed               0.0          0.494
  Yes                          10               1.02   0.83-1.25   0.864   Random              39.7         0.093
  **No. of cases**                                                                                          
  \<150                        8                1.17   0.93-1.47   0.171   Fixed               29.9         0.189
  ≥150                         5                1.07   0.79-1.45   0.669   Random              67.1         0.016

Abbreviations: OR, odds ratio; CI, confidence interval. *P* z, *P* value for Z test. *P* ~H~, *P* value based on Q test for between-study heterogeneity.
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